[1st trial of (2,2-diphenyl-3-methyl-4-morpholino)-butyryl pyrrolidine (R-875) in obstetrics].
D000698:Analgesia; D000700:Analgesics; D018712:Analgesics, Non-Narcotic / Q000627:therapeutic use*; D000758:Anesthesia; D000760:Anesthesia and Analgesia; D058633:Antipyretics; D001713:Biphenyl Compounds; D005260:Female; D006801:Humans; D007743:Labor, Obstetric; D060172:Morpholinos; D009774:Obstetrics; D011247:Pregnancy; D011759:Pyrrolidines
D000700:Analgesics; D018712:Analgesics, Non-Narcotic; D058633:Antipyretics; D001713:Biphenyl Compounds; D060172:Morpholinos; D011759:Pyrrolidines; C010574:biphenyl
ANALGESICS AND ANTIPYRETICS/therapeutic use; LABOR/anesthesia and analgesia
Premiers essais en obstétrique, du D. 2,2-diphényl 3 méthyl 4. morpholinobutyrylpyrrolidine (R 875).